{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:13:21Z","timestamp":1788394401267,"version":"build-2803163510"},"reference-count":177,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1586\/eri.09.46","type":"journal-article","created":{"date-parts":[[2009,8,14]],"date-time":"2009-08-14T16:01:20Z","timestamp":1250265680000},"page":"645-668","source":"Crossref","is-referenced-by-count":23,"title":["10 years\u2019 experience with the pneumococcal quinolone moxifloxacin"],"prefix":"10.1586","volume":"7","author":[{"given":"Olaf","family":"Burkhardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Welte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/43.suppl_2.1","volume":"43","author":"Blondeau","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00044011-199917050-00004","volume":"17","author":"Wise","year":"1999","journal-title":"Clin. Drug Invest."},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1086\/319377","volume":"32","author":"Krasemann","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1086\/428051","volume":"41","author":"Andriole","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"CIT0005","first-page":"193","volume":"25","author":"Vogel","year":"2002","journal-title":"Med. Monatsschr. Pharm."},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1086\/319371","volume":"32","author":"Dalhoff","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"CIT0007","unstructured":"Avalox\u00ae(Moxifloxacin) Product profile. Bayer Vital, Leverkusen, Germany, Revised May 2005."},{"key":"CIT0008","unstructured":"AVELOX\u00ae\/AVELOX\u00aeI.V. Prescribing information. Bayer Healthcare Pharmaceuticals Inc., Leverkusen, Germany, Revised October 2008."},{"key":"CIT0009","unstructured":"Avelox\u00ae400 mg film-coated tablets. Summary of product characteristics. Bayer Healthcare Pharmaceuticals Inc., Leverkusen, Germany, Revised March 2008."},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jac\/45.5.583","volume":"45","author":"Pestova","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/33.4.685"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1086\/321846","volume":"33","author":"Peterson","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1086\/319370","volume":"32","author":"Hooper","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1128\/AAC.00646-06","volume":"51","author":"LaPlante","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/13543784.8.2.181","volume":"8","author":"MacGowan","year":"1999","journal-title":"Exp. Opin. Invest. Drugs."},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijantimicag.2008.07.017","volume":"33","author":"Jacobs","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"CIT0017","first-page":"242","volume":"32","author":"Gottlieb","year":"2008","journal-title":"Commun. Dis. Intell."},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"ii87","DOI":"10.1093\/jac\/dkn355","volume":"62","author":"Farrell","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"ii97","DOI":"10.1093\/jac\/dkn356","volume":"62","author":"Morrissey","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1469-0691.2008.02027.x","volume":"14","author":"B\u00e9b\u00e9ar","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"CIT0021","unstructured":"Hsueh PR, Yang JC, King CHR.In vitroactivity of nemonoxacin againstHelicobacter pylori. Presented at:48th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Washington, DC, USA, 25\u201328 October 2008 (Poster C2-3931)."},{"key":"CIT0022","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1128\/AAC.48.3.1012-1016.2004","volume":"48","author":"Edmiston","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/jac\/dki348","volume":"56","author":"Edmiston","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.tripleo.2004.12.019","volume":"100","author":"Limeres","year":"2005","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"CIT0025","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1080\/0036554021000026963","volume":"34","author":"Burkhardt","year":"2002","journal-title":"Scand. J. Infect. Dis."},{"key":"CIT0026","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/jac\/40.6.797","volume":"40","author":"Klugman","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0027","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jac\/43.suppl_2.43","volume":"43","author":"Boswell","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0028","first-page":"5","volume":"2","author":"MacGowan","year":"1999","journal-title":"Moxifloxacin in Practice"},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1159\/000239474","volume":"42","author":"Dalhoff","year":"1996","journal-title":"Chemotherapy"},{"key":"CIT0030","first-page":"17","volume":"2","author":"Wiedemann","year":"1999","journal-title":"Moxifloxacin in Practice"},{"key":"CIT0031","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/jac\/47.6.811","volume":"47","author":"Lister","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0032","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1046\/j.1469-0691.2000.00166.x","volume":"6","author":"Rubinstein","year":"2000","journal-title":"Clin. Microbiol. Infect."},{"key":"CIT0033","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1086\/319375","volume":"32","author":"Schentag","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"CIT0034","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1086\/428053","volume":"41","author":"Wispelwey","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"CIT0035","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1128\/AAC.45.2.433-438.2001","volume":"45","author":"Blondeau","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0036","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0149-2918(00)88306-X","volume":"21","author":"Ballow","year":"1999","journal-title":"Clin. Ther."},{"key":"CIT0037","first-page":"15","volume":"3","author":"Stass","year":"2000","journal-title":"Moxifloxacin in Practice"},{"key":"CIT0038","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1128\/AAC.42.8.2060","volume":"42","author":"Stass","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-200140001-00001","volume":"40","author":"Stass","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"CIT0040","unstructured":"Avelox\u00ae400 mg\/250 ml solution for infusion. Summary of product characteristics. Bayer Healthcare Pharmaceuticals Inc., Leverkusen, Germany, Revised February 2007."},{"key":"CIT0041","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1179\/joc.2003.15.6.558","volume":"15","author":"Breilh","year":"2003","journal-title":"J. Chemother."},{"key":"CIT0042","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/43.suppl_2.83","volume":"43","author":"Stass","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0043","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1128\/AAC.43.11.2793","volume":"43","author":"Sullivan","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0044","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1128\/AAC.43.6.1508","volume":"43","author":"Wise","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0045","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1128\/AAC.47.10.3099-3103.2003","volume":"47","author":"Joukhadar","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0046","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1378\/chest.125.3.965","volume":"125","author":"Capitano","year":"2004","journal-title":"Chest"},{"key":"CIT0047","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1128\/AAC.48.2.638-640.2004","volume":"48","author":"Leone","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0048","unstructured":"Stass H, Joukhadar C, M\u00f6ller JG, M\u00fcller M. Concentrations of moxifloxacin at the focus of infection of patients suffering from erysipelas after a 400-mg single dose. Presented at:12th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Milan, Italy 24\u201327 April 2002 (Abstract P0178)."},{"key":"CIT0049","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jac\/43.suppl_2.69","volume":"43","author":"Siefert","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0050","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0009-9236(03)00201-7","volume":"74","author":"Simon","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"CIT0051","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/jac\/44.6.835","volume":"44","author":"Soman","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0052","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1128\/AAC.43.1.12","volume":"43","author":"Pascual","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0053","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1128\/AAC.01211-07","volume":"52","author":"Grayo","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0054","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1128\/AAC.01621-06","volume":"51","author":"Weiner","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0055","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1128\/AAC.00554-08","volume":"52","author":"Dooley","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0056","unstructured":"Stass H, Kubitza D, Wensing G. Pooled analysis of pharmacokinetics, safety and tolerability of single oral 400 mg moxifloxacin doses in patients with mild and moderate liver cirrhosis. Presented at:40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto, Canada, 17\u201320 September 2000 (Abstract P2269)."},{"key":"CIT0057","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1046\/j.0306-5251.2001.01557.x","volume":"53","author":"Stass","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"CIT0058","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/jac\/dki205","volume":"56","author":"Ittner","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0059","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/jac\/dkh421","volume":"54","author":"Fuhrmann","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0060","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2215\/CJN.01840506","volume":"1","author":"Czock","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"CIT0061","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/jac\/dkn212","volume":"62","author":"Barth","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0062","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jinf.2008.05.005","volume":"57","author":"Bonora","year":"2008","journal-title":"J. Infect."},{"key":"CIT0063","first-page":"128","volume":"12","author":"Rustomjee","year":"2008","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"CIT0064","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.rmed.2006.01.002","volume":"100","author":"Codecasa","year":"2006","journal-title":"Respir. Med."},{"key":"CIT0065","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1179\/joc.2003.15.1.66","volume":"15","author":"Valerio","year":"2003","journal-title":"J. Chemother."},{"key":"CIT0066","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10096-008-0587-2","volume":"28","author":"Al-Nawas","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"CIT0067","unstructured":"Cachovan G, Giersdorf I, Hallier Oet al.Efficacy and tolerability of moxifloxacin versus clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates (MOCLI Study). Presented at:18th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Barcelona, Spain, 19\u201322 April 2008 (Abstract O83)."},{"key":"CIT0068","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1523-5378.2007.00588.x","volume":"13","author":"Miehlke","year":"2008","journal-title":"Helicobacter"},{"key":"CIT0069","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00508-007-0807-2","volume":"119","author":"Bago","year":"2007","journal-title":"Wien. Klin. Wochenschr."},{"key":"CIT0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1183\/09031936.03.00045202","volume":"21","author":"Torres","year":"2003","journal-title":"Eur. Respir. J."},{"key":"CIT0071","unstructured":"Welte T, Burkhardt O, Marre R, Suttorp N for the CAPNETZ Study Group. CAPNETZ: Data on clinical efficacy of antibiotic therapy and mortality of CAP in Germany. Presented at:18th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Barcelona, Spain, 19\u201322 April 2008 (Abstract P844)."},{"key":"CIT0072","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1378\/chest.119.1.185","volume":"119","author":"Petitpretz","year":"2001","journal-title":"Chest"},{"key":"CIT0073","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1179\/joc.2007.19.5.536","volume":"19","author":"Iannini","year":"2007","journal-title":"J. Chemother."},{"key":"CIT0074","first-page":"748","volume":"16","author":"Fogarty","year":"1999","journal-title":"Infect. Med."},{"key":"CIT0075","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1128\/AAC.46.6.1746-1754.2002","volume":"46","author":"Finch","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0076","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1001\/archinte.159.21.2562","volume":"159","author":"Gleason","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"CIT0077","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1086\/498149","volume":"41","author":"Welte","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"CIT0078","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1086\/498520","volume":"42","author":"Anzueto","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"CIT0079","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1086\/587519","volume":"46","author":"Torres","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"CIT0080","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0954-6111(03)00166-5","volume":"97","author":"Lode","year":"2003","journal-title":"Respir. Med."},{"key":"CIT0081","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s15010-006-5120-x","volume":"34","author":"Wenisch","year":"2006","journal-title":"Infection"},{"key":"CIT0082","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1368-5031.2005.00699.x","volume":"59","author":"Fogarty","year":"2005","journal-title":"Int. J. Clin. Pract."},{"key":"CIT0083","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s10096-004-1214-5","volume":"23","author":"Hoeffken","year":"2004","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"CIT0084","unstructured":"Garau J, Breilmann J, Arvis P, Haverstock D, Choudhri SH. Moxifloxacin efficacy versus community-acquired pneumonia (CAP) caused byLegionella: a pooled analysis. Presented at:46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). San Francisco, USA, 27\u201330 September 2006 (Abstract L-1449)."},{"key":"CIT0085","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s15010-007-6193-x","volume":"35","author":"H\u00f6ffken","year":"2007","journal-title":"Infection"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-007-7043-6"},{"key":"CIT0087","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1086\/432626","volume":"41","author":"Polenakovik","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"CIT0088","first-page":"22","volume":"43","author":"Miravitlles","year":"2007","journal-title":"Arch. Bronconeumol."},{"key":"CIT0089","unstructured":"Anzueto A, Miravitlles M, Ewig S, Legnani D, Landen H, Stauch K. Greatest international anti-infective trial (GIANT): comparison of interim results from Europe and Asia. Presented at:ATS 2007 International Conference. San Francisco, USA (2007) (Poster A49)."},{"key":"CIT0090","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1378\/chest.125.3.953","volume":"125","author":"Wilson","year":"2004","journal-title":"Chest"},{"key":"CIT0091","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/jac\/44.4.501","volume":"44","author":"Wilson","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0092","first-page":"117","volume":"19","author":"Hautamaki","year":"2001","journal-title":"Todays Ther. Trends"},{"key":"CIT0093","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/rmed.1999.0708","volume":"94","author":"Chodosh","year":"2000","journal-title":"Respir. Med."},{"key":"CIT0094","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1053\/rmed.2000.0927","volume":"94","author":"DeAbate","year":"2000","journal-title":"Respir. Med."},{"key":"CIT0095","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/147323000102900408","volume":"29","author":"Schaberg","year":"2001","journal-title":"J. Int. Med. Res."},{"key":"CIT0096","first-page":"33","volume":"7","author":"Kreis","year":"2000","journal-title":"J. Clin. Outcomes Manage."},{"key":"CIT0097","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1179\/joc.2002.14.6.597","volume":"14","author":"Grassi","year":"2002","journal-title":"J. Chemother."},{"key":"CIT0098","first-page":"52","volume":"14","author":"Li-McLeod","year":"2001","journal-title":"Manag. Care Interface"},{"key":"CIT0099","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1517\/14656566.9.10.1755","volume":"9","author":"Miravitlles","year":"2008","journal-title":"Expert Opin. Pharmacother."},{"key":"CIT0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijantimicag.2006.11.033","volume":"30","author":"Petitpretz","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"CIT0101","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/147323000303100513","volume":"31","author":"Gehanno","year":"2003","journal-title":"J. Int. Med. Res."},{"key":"CIT0102","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.amjoto.2006.06.016","volume":"28","author":"Arrieta","year":"2007","journal-title":"Am. J. Otolaryngol."},{"key":"CIT0103","first-page":"303","volume":"17","author":"Baz","year":"1999","journal-title":"Todays Ther. Trends"},{"key":"CIT0104","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0149-2918(99)80046-0","volume":"21","author":"Burke","year":"1999","journal-title":"Clin. Ther."},{"key":"CIT0105","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1258\/002221503321046630","volume":"117","author":"Klossek","year":"2003","journal-title":"J. Laryngol. Otol."},{"key":"CIT0106","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1742-1241.2001.tb11045.x","volume":"55","author":"Rakkar","year":"2001","journal-title":"Int. J. Clin. Pract."},{"key":"CIT0107","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/rmed.1999.0769","volume":"94","author":"Siegert","year":"2000","journal-title":"Respir. Med."},{"key":"CIT0108","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6815-6-8","volume":"6","author":"Ariza","year":"2006","journal-title":"BMC Ear Nose Throat Disord."},{"key":"CIT0109","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0149-2918(04)90021-5","volume":"26","author":"Johnson","year":"2004","journal-title":"Clin. Ther."},{"key":"CIT0110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1185\/030079906X80620","volume":"22","author":"Keating","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"key":"CIT0111","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2147\/tcrm.2006.2.4.417","volume":"2","author":"Guay","year":"2006","journal-title":"Ther. Clin. Risk Manag."},{"key":"CIT0112","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijantimicag.2005.07.017","volume":"26","author":"Giordano","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"CIT0113","unstructured":"Vick-Fragoso R, Hern\u00e1ndez-Oliva G, Cruz-Alc\u00e1zar J, Am\u00e1bile-Cuevas CF, Arvis P, Bogner J. Sequential IV\/PO moxifloxacin (MXF) as effective as co-amoxiclav (AMC) against complicated skin and skin structure infections (cSSSIs). Presented at:20th European Congress on Surgical Infections. Frankfurt, Germany (2007) (Poster P4)."},{"key":"CIT0114","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/jac\/dkm130","volume":"60","author":"Lipsky","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0115","doi-asserted-by":"crossref","unstructured":"Bogner JR, Arvis P, Choudhri S, Pertel P, Brielmann JM. Clinical and bacteriological efficacy of sequential intravenous (IV) to oral (PO) moxifloxacin in hospitalised patients with major skin abscesses. Presented at:20th European Congress on Surgical Infections. Frankfurt, Germany (2007) (Poster P30).","DOI":"10.1016\/S0924-8579(07)71862-9"},{"key":"CIT0116","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1179\/joc.2009.21.2.170","volume":"21","author":"Wei\u00df","year":"2009","journal-title":"J. Chemother."},{"key":"CIT0117","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/01.sla.0000230024.84190.a8","volume":"244","author":"Malangoni","year":"2006","journal-title":"Ann. Surg."},{"key":"CIT0118","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/sti.2005.019109","volume":"82","author":"Ross","year":"2006","journal-title":"Sex. Transm. Infect."},{"key":"CIT0119","author":"Heystek","year":"2009","journal-title":"Int. J. STD AIDS"},{"key":"CIT0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/01.STR.0000109041.89959.4C","volume":"35","author":"Meisel","year":"2004","journal-title":"Stroke"},{"key":"CIT0121","doi-asserted-by":"crossref","first-page":"e2158","DOI":"10.1371\/journal.pone.0002158","volume":"3","author":"Harms","year":"2008","journal-title":"PLoS ONE"},{"key":"CIT0122","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2165\/00044011-200424080-00001","volume":"24","author":"Elies","year":"2004","journal-title":"Clin. Drug Investig."},{"key":"CIT0123","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2165\/00044011-200424080-00002","volume":"24","author":"Koch","year":"2004","journal-title":"Clin. Drug Investig."},{"key":"CIT0124","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2165\/00044011-200424080-00003","volume":"24","author":"Koch","year":"2004","journal-title":"Clin. Drug Investig."},{"key":"CIT0125","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/00044011-200525110-00002","volume":"25","author":"Barth","year":"2005","journal-title":"Clin. Drug Invest."},{"key":"CIT0126","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1345\/aph.1C066","volume":"38","author":"Faich","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"CIT0127","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2165\/00044011-200121120-00002","volume":"21","author":"Landen","year":"2001","journal-title":"Clin. Drug Invest."},{"key":"CIT0128","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2165\/00044011-200626120-00007","volume":"26","author":"Schaberg","year":"2006","journal-title":"Clin. Drug Investig."},{"key":"CIT0129","unstructured":"Bogner JR, Wild T, Landen H. Avelox\u00aeroutine treatment of complicated skin and skin structure infections (ARTOS) \u2013 first interim results of this international non-interventional study. Presented at:20th European Congress on Surgical Infections. Frankfurt, Germany (2007) (Poster P6)."},{"key":"CIT0130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1473-3099(03)00658-3","volume":"3","author":"Dalhoff","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"CIT0131","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1016\/S0024-3205(03)00611-8","volume":"73","author":"Hall","year":"2003","journal-title":"Life Sci."},{"key":"CIT0132","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1034\/j.1600-0609.2001.066005287.x","volume":"66","author":"Shalit","year":"2001","journal-title":"Eur. J. Haematol."},{"key":"CIT0133","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1128\/AAC.48.6.1974-1982.2004","volume":"48","author":"Weiss","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0134","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1128\/AAC.47.12.3704-3707.2003","volume":"47","author":"Choi","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0135","first-page":"13","volume":"35","author":"Dalhoff","year":"2007","journal-title":"Infection"},{"key":"CIT0136","unstructured":"Trautmann M, Scheibe C, M\u00f6ricke A. Influence of moxifloxacin on endotoxin release ofEscherichia coli. Presented at:12th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Milan, Italy (2002) (Poster 1066)."},{"key":"CIT0137","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1128\/AAC.49.12.5119-5122.2005","volume":"49","author":"Ulrich","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0138","doi-asserted-by":"crossref","unstructured":"Hammerschmitt S, Berlinghoff R, Kuhn H, Wirtz H. Moxifloxacin verbessert die Toleranz alveol\u00e4rer Typ-2-Zellen gegen\u00fcber mechanischer Belastung. Presented at: 49Kongress der Deutschen Gesellschaft f\u00fcr Pneumologie und Beatmungsmedizin (DGP). L\u00fcbeck, Germany (2008) (Poster P139).","DOI":"10.1055\/s-2008-1074358"},{"key":"CIT0139","unstructured":"Rotondetto S, Spiteri M, Thomson C.In vitroeffects of moxifloxacin in human respiratory ciliary kinetics. Presented at:3rd European Congress of Chemotherapy (ECC). Madrid, Spain (2000) (Poster 176)."},{"key":"CIT0140","first-page":"28","volume":"10","author":"Gamarra","year":"2004","journal-title":"Klinik & Forschung"},{"key":"CIT0141","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijantimicag.2007.06.029","volume":"30","author":"Roveta","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"CIT0142","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijantimicag.2005.12.003","volume":"27","author":"Kalteis","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"CIT0143","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0149-2918(04)90170-1","volume":"26","author":"Ball","year":"2004","journal-title":"Clin. Ther."},{"key":"CIT0144","unstructured":"Iannini PB, Kubin R, Reiter C. Over 10 million patient uses: an update on the safety profile of oral moxifloxacin. Presented at:42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). San Diego, USA (2002) (Poster L-374)."},{"key":"CIT0145","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00002018-200528050-00007","volume":"28","author":"Andriole","year":"2005","journal-title":"Drug Saf."},{"key":"CIT0146","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1378\/chest.128.5.3398","volume":"128","author":"Morganroth","year":"2005","journal-title":"Chest"},{"key":"CIT0147","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1086\/428055","volume":"41","author":"Owens","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"CIT0148","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2165\/00002018-200427090-00005","volume":"27","author":"Gavin","year":"2004","journal-title":"Drug Saf."},{"key":"CIT0149","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2165\/00002018-200730080-00007","volume":"30","author":"Johannes","year":"2007","journal-title":"Drug Saf."},{"key":"CIT0150","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1128\/AAC.00592-06","volume":"50","author":"Dhalla","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0151","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1086\/500264","volume":"42","author":"Beaulieu","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"CIT0152","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cld.2007.06.009","volume":"11","author":"Polson","year":"2007","journal-title":"Clin. Liver Dis."},{"key":"CIT0153","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1183\/09031936.00092507","volume":"32","author":"Kothe","year":"2008","journal-title":"Eur. Respir. J."},{"key":"CIT0154","unstructured":"Leal del Rosal P, Fabian G, Vick-Fragaso Ret al.Efficacy and safety of moxifloxacin (MXF) vs. cephalexin (with or without metronidazole) in the treatment of mild to moderate uncomplicated skin and skin structure infections (uSSSI) (Abstract). Proceedings of:39th Interscience Conference on Antimicrobial Agents and Chemotherapy.San Diego, CA, USA, 1076, 26\u201329 September 1999."},{"key":"CIT0155","first-page":"493","volume":"44","author":"Leal del Rosal","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0156","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/jac\/dkn110","volume":"61","author":"Kanellakopoulou","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0157","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijantimicag.2007.08.025","volume":"31","author":"Wagenlehner","year":"2008","journal-title":"Int. J. Antimicrob. Agents."},{"key":"CIT0158","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/jac\/dkl050","volume":"57","author":"Esposito","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0159","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/jac\/dkf014","volume":"49","author":"Gehanno","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0160","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1080\/00365540600664076","volume":"38","author":"Burkhardt","year":"2006","journal-title":"Scand. J. Infect. Dis."},{"key":"CIT0161","unstructured":"Majcher-Peszynska J, Karrasch K, Sa\u00df Met al.Tissue penetration and pharmacokinetics of moxifloxacin in diabetic foot infections: an interim analysis. Presented at:16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Nice, France, 1\u20134 April 2006 (Abstract P1516)."},{"key":"CIT0162","unstructured":"Stass H, Joukhadar C, M\u00f6ller JG, M\u00fcller M. Penetration of moxifloxacin into the infected tissues of patients suffering from diabetic foot infections determined by microdialysis. Presented at:12th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Milan, Italy, 24\u201327 April 2002 (Abstract P0179)."},{"key":"CIT0163","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/jac\/dkl091","volume":"57","author":"Malincarne","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0164","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ijantimicag.2006.08.019","volume":"28","author":"Metallidis","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"CIT0165","first-page":"44","volume":"10","author":"Gusinde","year":"2004","journal-title":"Klinik & Forschung"},{"key":"CIT0166","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/AAC.43.10.2345","volume":"43","author":"M\u00fcller","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"CIT0167","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/jac\/dkh173","volume":"53","author":"Wirtz","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0168","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00044011-200828020-00001","volume":"28","author":"Rink","year":"2008","journal-title":"Clin. Drug Investig."},{"key":"CIT0169","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/jac\/dkl305","volume":"58","author":"Stass","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0170","unstructured":"Metallidis S, Lazaraki G, Tsona Aet al.Serum and ascitic fluid concentrations following a single IV dose of 400 mg moxfloxacin. Presented at:16th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Nice, France, 1\u20134 April 2006 (Abstract R1922)."},{"key":"CIT0171","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2036.2005.02567.x","volume":"22","author":"Schwab","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"CIT0172","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/jac\/dkl353","volume":"58","author":"Wacke","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"CIT0173","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijgo.2008.02.020","volume":"102","author":"Stass","year":"2008","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"CIT0174","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1179\/joc.2006.18.5.485","volume":"18","author":"Wagenlehner","year":"2006","journal-title":"J. Chemother."},{"key":"CIT0175","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/IAE.0b013e31814fb0ed","volume":"28","author":"Lott","year":"2008","journal-title":"Retina"},{"key":"CIT0176","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jemermed.2004.02.023","volume":"27","author":"Katz","year":"2004","journal-title":"J. Emerg. Med."},{"key":"CIT0177","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1742-1241.2000.tb10911.x","volume":"54","author":"Parish","year":"2000","journal-title":"Int. J. Clin. Pract."}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/eri.09.46","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T10:17:38Z","timestamp":1685096258000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1586\/eri.09.46"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":177,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,1,10]]},"published-print":{"date-parts":[[2009,8]]}},"alternative-id":["10.1586\/eri.09.46"],"URL":"https:\/\/doi.org\/10.1586\/eri.09.46","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}